Condition
Chest Syndrome
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Completed2
Unknown2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05715879Completed
Covid-19 Infection and Long-term Cardiovascular Symptoms
NCT04709900Not ApplicableRecruiting
CT Stress Myocardial Perfusion, Fractional Flow Reserve and Angiography in Patients With Stable Chest Pain Syndromes
NCT05596721Phase 4Unknown
Azithromycin Treatment for Non-eosinophilic Chest Tightness Variant Asthma
NCT03237221Completed
Clinical Characteristics, Treatment and Prognosis of Chest Tightness Variant Asthma
NCT04322422Not ApplicableUnknown
Clinical Characteristics and Treatment of Chest Tightness Variant Asthma
Showing all 5 trials